Biotechnology company IBio Inc. (NYSE: IBIO) has indicated that without more cash, it faces the threat of liquidation.

The company raised doubt about continuing as a going concern, or without the threat of liquidation, in a May 20 10-Q filing with the U.S. Securities and Exchange Commission, saying the status is caused by a history of losses, negative cash from operations and limited cash resources.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.